FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202899050> ?p ?o ?g. }

• W3202899050 abstract "Abstract Background Hepcidin, an acute phase reactant protein produced in the liver, is a key regulator of iron homeostasis. Because of its renal elimination and regulation by inflammation, it is possible that progressive renal insufficiency leads to altered hepcidin metabolism. Aim of the work to assess effect of HCV treatment on hepcidin levels in regular heamodialysis patients and its relation to iron status. Patients and Methods This cross sectional study was conducted on 45 ESRD patients on regular hemodialysis. All candidates included in this study subjected to careful history taking, full clinical examination and investigations (including complete blood count, HCVAb, HBVsAg and HIVAb). All patients had positive antibodies for hepatitis C; however, all of them had negative PCR and negative HIV, HBV antibodies. Results In our study, dry weight ranged from 46 to 117 kg with mean 77.36. Weight gain ranged from 2 to 5 kg with mean 3.09.About 87% of patients had LTAVF access. About 12 patients (27%) received blood transfusion once. Timing of transfusion ranged from 4 to 60 month with median of 24 months. Regarding frequency of epoetin dose, 11 patients (24.4%) did not receive epoetin, 16 patients (35.6%) received it twice/week. Only 3 patients (6.7%) received iron therapy for time ranging from 3 to 5 months with mean of 4 months. Mean Hb concentration in our study population was 10.11 ±1.64 gm/dl. The mean of iron was 64.22 ±19.52, TIBC was 409.96 ± 67.85, ferritin was 394.56 ± 239.22 and TSAT% was 22.6 ±7.36. The mean serum hepcidin was 218.51 ±127. Our study demonstrated that increase in serum hepcidin is associated with lower serum Hb and iron levels. On the other hand, there is statistically significant positive correlation between serum hepcidin and both serum ferritin and transferrin saturation. Conclusion Median hepcidin value is elevated in dialysis ESRD patients due to increased inflammation and decreased clearance of hepcidin. Also serum hepcidin levels were lowered in HCV patients. Therefore ESRD patients on maintenance HD after treatment of HCV infection showed elevated levels of serum hepcidin." @default.
• W3202899050 created "2021-10-11" @default.
• W3202899050 creator A5030166137 @default.
• W3202899050 creator A5078477966 @default.
• W3202899050 creator A5089708014 @default.
• W3202899050 creator A5089838425 @default.
• W3202899050 date "2021-10-01" @default.
• W3202899050 modified "2023-09-26" @default.
• W3202899050 title "Role of Hepcidin as a biomarker for iron status in patients on regular hemodialysis after treatment of hepatitis C virus" @default.
• W3202899050 doi "https://doi.org/10.1093/qjmed/hcab100.117" @default.
• W3202899050 hasPublicationYear "2021" @default.
• W3202899050 type Work @default.
• W3202899050 sameAs 3202899050 @default.
• W3202899050 citedByCount "0" @default.
• W3202899050 crossrefType "journal-article" @default.
• W3202899050 hasAuthorship W3202899050A5030166137 @default.
• W3202899050 hasAuthorship W3202899050A5078477966 @default.
• W3202899050 hasAuthorship W3202899050A5089708014 @default.
• W3202899050 hasAuthorship W3202899050A5089838425 @default.
• W3202899050 hasBestOaLocation W32028990501 @default.
• W3202899050 hasConcept C126322002 @default.
• W3202899050 hasConcept C203014093 @default.
• W3202899050 hasConcept C2522874641 @default.
• W3202899050 hasConcept C2776244011 @default.
• W3202899050 hasConcept C2776408679 @default.
• W3202899050 hasConcept C2776768029 @default.
• W3202899050 hasConcept C2778063415 @default.
• W3202899050 hasConcept C2778248108 @default.
• W3202899050 hasConcept C2778319317 @default.
• W3202899050 hasConcept C2778917026 @default.
• W3202899050 hasConcept C2779875672 @default.
• W3202899050 hasConcept C2908647359 @default.
• W3202899050 hasConcept C71924100 @default.
• W3202899050 hasConcept C90924648 @default.
• W3202899050 hasConcept C99454951 @default.
• W3202899050 hasConceptScore W3202899050C126322002 @default.
• W3202899050 hasConceptScore W3202899050C203014093 @default.
• W3202899050 hasConceptScore W3202899050C2522874641 @default.
• W3202899050 hasConceptScore W3202899050C2776244011 @default.
• W3202899050 hasConceptScore W3202899050C2776408679 @default.
• W3202899050 hasConceptScore W3202899050C2776768029 @default.
• W3202899050 hasConceptScore W3202899050C2778063415 @default.
• W3202899050 hasConceptScore W3202899050C2778248108 @default.
• W3202899050 hasConceptScore W3202899050C2778319317 @default.
• W3202899050 hasConceptScore W3202899050C2778917026 @default.
• W3202899050 hasConceptScore W3202899050C2779875672 @default.
• W3202899050 hasConceptScore W3202899050C2908647359 @default.
• W3202899050 hasConceptScore W3202899050C71924100 @default.
• W3202899050 hasConceptScore W3202899050C90924648 @default.
• W3202899050 hasConceptScore W3202899050C99454951 @default.
• W3202899050 hasIssue "Supplement_1" @default.
• W3202899050 hasLocation W32028990501 @default.
• W3202899050 hasOpenAccess W3202899050 @default.
• W3202899050 hasPrimaryLocation W32028990501 @default.
• W3202899050 hasRelatedWork W1980636878 @default.
• W3202899050 hasRelatedWork W2021934308 @default.
• W3202899050 hasRelatedWork W2330343258 @default.
• W3202899050 hasRelatedWork W2366649397 @default.
• W3202899050 hasRelatedWork W2409952055 @default.
• W3202899050 hasRelatedWork W2748375747 @default.
• W3202899050 hasRelatedWork W3005466965 @default.
• W3202899050 hasRelatedWork W4285387551 @default.
• W3202899050 hasRelatedWork W4320709700 @default.
• W3202899050 hasRelatedWork W3126394008 @default.
• W3202899050 hasVolume "114" @default.
• W3202899050 isParatext "false" @default.
• W3202899050 isRetracted "false" @default.
• W3202899050 magId "3202899050" @default.
• W3202899050 workType "article" @default.